|
COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 5,1999 PSA#2277311th HSW/YAK, 8107 13th St, Brooks AFB, TX 78235-5218 65 -- REQUEST FOR INFORMATION (RFI) SYNOPSIS ANNOUNCEMENT FOR THE
COMMERCE BUSINESS DAILY: MEDICAL EQUIPMENT, AEROMEDICAL EVACUATION,
OXYGEN GENERATING SYSTEMS, COMPRESSORS, CRYOGENICS SOL F41624-99-R-1002
DUE 030499 POC David M. Foote, (210) 925-6831, Michael J. Nannery,
(210) 536-4559, or Larry Looper, (210) 536-4458 WEB: RFP not
applicable, UNDER CONSTRUCTION. E-MAIL: To contact contract specialist,
see e-mail address, davfoote@ldgate1.kelly.af.mil. This is not a notice
of solicitation. The 311th Human Systems Wing at Brooks AFB is seeking
information on the commercial capabilities and costs of medical
equipment, technologies or systems that support the Air Force Medical
Service mission to provide Patient Therapeutic quality oxygen in
Aeromedical evacuation (AE) aircraft, C-5, C-130, KC-10, and KC-135.
Background -- The current system used to support patient oxygen
requirements in the Air Force Aeromedical evacuation system (AES) is
the Patient Therapeutic Liquid Oxygen System (PTLOX). This system
depends upon the availability of liquid oxygen (LOX) and is labor
intensive to support and maintain. Changes in aircraft oxygen systems
from LOX dependent systems to On-Board Oxygen Generating Systems
(OBOGS), as well as changes in operational employment of forces has
made it increasingly difficult to find LOX to support the PTLOX systems
in forward deployed areas. Additionally, as fewer airframes depend upon
LOX, the ability to maintain these systemsin garrison and while
deployed continues to diminish. Unlike the PTLOX system, current OBOGS
do not provide 100 percent oxygen. Integration of OBOGS into existing
airframes easily meets flight crew oxygen requirements. However, many
patient conditions, as well as international standards for patient
care, require the availability of 100 percent oxygen for therapeutic
purposes. Currently, improved oxygen system components and packaging
are needed that will directly meet AES and airlift power, weight, and
size constraints, and deliver 100 percent oxygen to satisfy operational
requirements. Information on technologies that support on-board oxygen
generation is being sought. In relation to the provision of on-board
AES missions, either of two (2) separate concepts of operation is
acceptable: (1) Single piece system should have the capability to
produce, store and deliver therapeutic oxygen in a single, integrated
system that is man-portable and capable of integration onto all current
and potential airframes usedin fixed-wing patient evacuation. Equipment
should have the following characteristics: (a) Human factors: portable,
compact, and compatible with use in aircraft, with the complete system
less than 300 pounds total when filled to capacity and not exceeding
2 ft. x 3 ft. x 5 ft. (2 ft. being critical -- the width of the patient
litter); (b) Oxygen Generation -- minimum 33 (45 preferred) liters per
minute of gaseous oxygen at 50 psig for 16 hours; (b) Oxygen
Generation -- minimum 33 (45 preferred) liters per minute of gaseous
oxygen at 50 psig for 16 hours; (c) Oxygen Distribution -- 3
distribution outlets required, capability to fill oxygen tanks,
desired; (d) Oxygen Quality > or equal to 99.0 percent purity; (e)
Emergency Operation -- must maintain oxygen delivery during power
termination for 2 hours minimum (4 hours desired); (f) Operating
Temperatures -- operate in temperatures of -24 to +140 degrees
Fahrenheit; (g) Electrical -- operate on worldwide hospital and
aircraft AC current, not to exceed 115-220 VAC, 50-400 HZ, 15 amps (10
amps maximum preferred), 5,000 watts (total), 28 VDC; and (h)
Certification -- Food and Drug Administration (FDA) certification of
conforming to FDA requirements for medical devices and U.S.
Pharmacopoeia (USP) requirements for hospital-grade oxygen. (2) Two
piece system should have the capability to produce, store and transfer
therapeutic oxygen to a "fly-away" component, which would be used to
deliver the therapeutic oxygen to meet patient requirements. Transfer
from production system to delivery system should be automated.
Equipment should have the following characteristics: (a) Human Factors:
Fly-away portion must be portable, compact, and compatible with use in
aircraft and weigh less than 300 pounds when filled to capacity, and
not exceeding 2 ft. x 3 ft. x 5 ft; Ground-based portion must be mobile
and easily transportable; (b) Oxygen Generation -- minimum 33 (45
preferred) liters per minute of gaseous oxygen at 50 psig for 16 hours;
(c) Oxygen Distribution: Flyaway unit must have minimum of three
distribution outlets; ground unit must fill one flyaway unit (three
simultaneously, desired) and have capability to fill high-pressure
oxygen tanks (desired); (d) Oxygen Quality: > or equal to 99.0
percent purity; (e) Emergency Operation- Fly-away unit must maintain
oxygen delivery during power termination for 2 hours minimum (4 hours
desired); (f) Operating Temperatures -- operate in temperatures of -24
to +140 degrees Fahrenheit; (g) Electrical -- operate on worldwide
hospital and aircraft AC current not to exceed 115-220 VAC, 50-400 HZ,
15 amps (10 amps preferred), 5,000 watts (total), 28 VDC; and (h)
Certification -- Food and Drug Administration (FDA) certification of
conforming to FDA requirements for medical devices and U.S.
Pharmacopoeia (USP) requirements for hospital-grade oxygen. Responses
for commercially available or developmental equipment should be
submitted. If commercially available items were procured by the Air
Forceat a future date, minimal development funding is expected to be
required. Funding that would be available for equipment acquisition
would be for field testing to ensure reliability, maintainability,
ruggedness (vibration, drop, etc.), and environmental (heat, cold,
humidity, etc.), and compatibility to bring equipment into compliance
with those requirements. Submissions should identify how the equipment
is capable of meeting the above specifications. Responses should
include: (1) technical specifications that include all performance
capabilities and required interfaces, i.e., power, environmental, etc.;
(2) results of all testing that has been accomplished to date and any
planned future testing, along with a schedule to include
expected/actual performance/capability, reliability, maintainability
and in-flight use; (3) current production rates of the equipment and
approximate delivery schedule; (4) logistics concepts for repairing and
maintaining the equipment; (5) any cost data available for the
equipment including unit, maintenance and operational life cycle,
either projected or actual; (6) manufacturing standards of the company;
and (7) current users of equipment. Capability statements, excluding
resumes, shall be submitted to 311 HSW/YAMA, 8107 13th St, Brooks AFB,
TX 78235-5218, within 30 days of publication of this notice. This is
a sources sought synopsis. This is not a request for proposal and in no
way commits the Government to an award of contract. Reimbursement of
any cost regarding the preparation of proposals or bids will not be
made. TECHNICAL QUESTIONS MAY BE DIRECTED TO MR. LARRY LOOPER, 311
HSW/XRS, (210) 536-4458. All non-technical and contractual questions
should be addressed to 311 HSW/YAMA, David M. Foote, Contract
Specialist, (210) 925-6831 or Michael J. Nannery, Contracting Officer,
(210) 536-4559. Posted 02/03/99 (W-SN294323). (0034) Loren Data Corp. http://www.ld.com (SYN# 0315 19990205\65-0006.SOL)
65 - Medical, Dental and Veterinary Equipment and Supplies Index Page
|
|